What is the study about?
Study 1: The goal of this study is to develop new ways to measure brain health using behaviour testing and brain wave monitoring (electroencephalogram (EEG)). This will help with early diagnosis of mild cognitive impairment and dementia, identifying different subtypes of these disorders, and predicting how they will progress.
Study 2: This pilot study uses the Muse headband and mobile application to provide people with mild cognitive impairment and caregivers with real-time feedback about their brain waves during meditation. The goals of this study are to test the study design, assess the effects of getting brain wave feedback while meditating, and see whether Muse’s platform will be accepted as an intervention by participants.
Eligibility – Who can participate?
Be 55 to 90 years of age
Either have no cognitive impairment or a diagnosis of any of the following:
Mild cognitive impairment (of any kind)
Any neurodegenerative disorder (e.g., Parkinson’s Disease, Lewy Body disease, Alzheimer’s disease, Alzheimer’s disease with cerebrovascular disease, vascular dementia)
- Study 1 (biomarkers): One visit for about 4 hours
- Study 2 (meditation): 20 hours over a period of 7-8 weeks, including 3 visits to Baycrest and time spent meditating at home
TDRA study investigator
Dr. Morris Freedman
Alzheimer’s disease, Frontotemporal dementia (FTD), Healthy volunteer, Mild cognitive impairment, Parkinson /Lewy body spectrum disease, Parkinson’s disease, People with vascular cognitive impairment, People with white matter disease